Consensus Nurix Therapeutics, Inc.

Equities

NRIX

US67080M1036

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
16.19 ^USD	-2.41%		+16.14%	+56.88%

May. 20	Nurix Therapeutics Names New Board Chair	MT
May. 14	Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target	MT

Evolution of the average Target Price on Nurix Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

c03034b7dcbd8bae538231f045.OSrXSqiieJSe88UEflX3qceQYWAsd-XEwcMhNSeE-ZM.cWSUMPDmAc3OgYNHCQyEwKDhKFNHOp-nm_ZnQWHCmsV3YpAI_eki0MSWiA~f7e5271a1e7be6dbcb3bd7fc554cde9e

Analyst Recommendations on Nurix Therapeutics, Inc.

Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target	May. 14	MT
Nurix Therapeutics Prices Upsized Stock Offering at $15 a Share	Apr. 12	MT
Baird Adjusts Price Target on Nurix Therapeutics to $25 From $24, Maintains Outperform Rating	Apr. 11	MT
RBC Lifts Price Target on Nurix Therapeutics to $23 From $22, Keeps Outperform Rating, Speculative Risk Qualifier	Apr. 11	MT
Morgan Stanley Adjusts Nurix Therapeutics' Price Target to $10 From $9, Keeps Equalweight Rating	Feb. 26	MT
HC Wainwright Cuts Nurix Therapeutics Price Target to $19 From $35, Maintains Buy Rating	Feb. 20	MT
RBC Cuts Price Target on Nurix Therapeutics to $22 From $24, Keeps Outperform, Speculative Risk	Feb. 16	MT
RBC Cuts Price Target on Nurix Therapeutics to $24 From $29, Keeps Outperform, Speculative Risk	Nov. 02	MT
RBC Trims Price Target on Nurix Therapeutics to $29 From $30, Keeps Outperform, Speculative Risk	23-10-13	MT
HC Wainwright Adjusts Price Target on Nurix Therapeutics to $35 From $33, Keeps Buy Rating	23-09-08	MT
HC Wainwright Adjusts Nurix Therapeutics Price Target to $33 From $53, Maintains Buy Rating	23-07-24	MT
Morgan Stanley Adjusts Price Target on Nurix Therapeutics to $12 From $11, Maintains Equal-Weight Rating	23-07-17	MT
Barclays Initiates Nurix Therapeutics at Overweight With $20 Price Target	23-03-09	MT
Oppenheimer Initiates Coverage on Nurix Therapeutics With Outperform Rating, $25 Price Target	23-02-28	MT
Stifel Adjusts Price Target on Nurix Therapeutics to $31 From $37, Maintains Buy Rating	23-02-14	MT
JPMorgan Chase Adjusts Price Target on Nurix Therapeutics to $36 From $37, Maintains Overweight Rating	23-02-13	MT
Berenberg Bank Adjusts Nurix Therapeutics' Price Target to $30 From $48, Maintains Buy Rating	23-02-13	MT
Needham Trims Price Target on Nurix Therapeutics to $31 From $32, Maintains Buy Rating	23-02-10	MT
RBC Cuts Price Target on Nurix Therapeutics to $30 From $39, Maintains Outperform, Speculative Risk	23-02-10	MT
Morgan Stanley Starts Nurix Therapeutics at Equalweight with $11 Price Target	22-10-11	MT
HC Wainwright Trims Nurix Therapeutics' Price Target to $53 From $54, Maintains Buy Rating	22-10-07	MT
Needham Adjusts Nurix Therapeutics' Price Target to $32 from $38, Keeps Buy Rating	22-07-12	MT
HC Wainwright Adjusts Price Target on Nurix Therapeutics to $54 From $60, Reiterates Buy Rating	22-07-11	MT
Baird Adjusts Price Target on Nurix Therapeutics to $32 From $41, Keeps Outperform Rating	22-07-08	MT
JPMorgan Adjusts Price Target on Nurix Therapeutics to $37 From $46, Reiterates Overweight Rating	22-07-08	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

16.19 USD

Average target price

24.67 USD

Spread / Average Target

+52.36%

High Price Target

35 USD

Spread / Highest target

+116.18%

Low Price Target

14 USD

Spread / Lowest Target

-13.53%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Nurix Therapeutics, Inc.

Stephens Inc.
Baird
RBC Capital Markets
Morgan Stanley
HC Wainwright
Barclays
Oppenheimer
Stifel Nicolaus
Berenberg Bank
JPMorgan Chase
Needham & Co.
Piper Sandler
Wells Fargo Securities
SVB Leerink
J.P. Morgan Chase

Ratings for Nurix Therapeutics, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar